ÂÜÀòÂÒÂ×

Tanja Arnouk is currently the Head of Viral Vector Processing Development & Production at ProBioGen AG since July 2022. Previously, Tanja worked as a Scientist at Boehringer Ingelheim from April 2019 to July 2022. Tanja also served as a Phd Candidate at Otto-von-Guericke-University Magdeburg from November 2015 to July 2019. With a Master of Science in Biopharmazeutische Technologie and a Diplom in Biotechnology, their expertise in the field is well-established. Tanja has also gained experience as a Project Manager at ehc-memtec and as a trainee at Experimental Ophtalmology at the Johannes Gutenberg University Mainz.